Endocrine Testing for Infertility Market Research Report - Segmentation by Test Type (Estradiol Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Progesterone Test, Prolactin Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Others); Technology (Chromatography, Immunoassay, Mass Spectroscopy, Others); End User (Clinical Laboratories, Diagnostic Centers, Hospitals, Others); and Region - Size, Share, Growth Analysis | Forecast (2023 – 2030)
Endocrine Testing for Infertility Market Size (2023-2030)
Global Endocrine Testing for Infertility Market is estimated to be worth USD 294.43 Million in 2022 and is projected to reach a value of USD 557.61 Billion by 2030, growing at a CAGR of 8.31% during the forecast period 2023-2030.
Endocrine tests are medical procedures performed by endocrinologists to assess hormone levels and detect issues with organs related to the endocrine system. They help determine hormone levels, evaluate gland function, identify underlying causes of endocrine problems, and confirm diagnoses. These tests can diagnose specialized fields and hormonal diseases involving various glands and tumors. They include urine and blood tests, imaging scans, and specialized procedures like bone density tests and thyroid scans. Endocrine tests assess hormone functioning, which affects secondary sexual characteristics, fertility, growth, metabolism, and sleep. They are conducted for reasons such as addressing symptoms of endocrine disorders or fatigue.
Before an endocrine test, preparation typically involves fasting, consuming only specified beverages, and following medication instructions. Patients are advised not to smoke and to remain physically active within the designated area during the test. The expectations of an endocrine test vary depending on the type of test being conducted. Hormone levels are assessed through urine and blood tests, while imaging tests help identify abnormalities or tumors affecting the endocrine glands. Treating endocrine disorders can be complex due to the interconnected nature of hormone levels. Regular blood work may be required to monitor progress, adjust treatment plans, or modify medications. Diabetes, adrenal insufficiency, Cushing's disease, growth hormone issues, hyperthyroidism, hypopituitarism, multiple endocrine neoplasia, polycystic ovary syndrome (PCOS), and precocious puberty can all be identified by abnormal endocrine test findings. The interpretation of abnormal results depends on the specific testing method utilized.
Global Endocrine Testing for Infertility Market Drivers:
The declining fertility rate is fueling the growth of the global endocrine testing for infertility market.
The global industry for endocrine testing for infertility is experiencing growth primarily due to a decrease in fertility rates worldwide. This decrease in infertility can be ascribed to a variety of factors, including a rising tendency of individuals to wedding at a later age, an ascent in age-related infertility, the incidence of obesity, and the existence of chronic conditions such as diabetes. As per United Nations, the worldwide fertility rate is projected to fall to 2.4 children per woman by 2030 and 2.2 children per woman by 2050. This drop in fertility rates on a global scale is anticipated to drive the demand for endocrine testing services for infertility.
The increasing WHO initiative towards fertility care is another factor contributing to the growth of the global endocrine testing for infertility market.
The acknowledgment and efforts of the World Health Organization (WHO) to improve fertility care and address infertility serve as a market driver for global endocrine testing for the infertility market. WHO's initiatives include conducting global research, developing guidelines, updating normative products, collaborating with stakeholders, and providing technical support at the country level. These initiatives aspire to boost access to high-quality family planning services, including fertility care, as well as to establish worldwide reproductive health norms and standards. The WHO's focus on policy dialogue, data collection, and resource allocation contributes to the growth of the market by creating an enabling environment, raising awareness, and strengthening health systems. Overall, WHO's efforts drive the expansion and advancement of the fertility care market worldwide.
Global Endocrine Testing for Infertility Market Challenges:
The global endocrine testing for infertility market is encountering challenges, primarily in terms of the costly development of accurate endocrine tests for infertility. Devising technologies for endocrine testing can be costly due to the intricate nature of the endocrine system and the need to measure numerous hormones and biomarkers. Creating tests that are accurate and dependable takes considerable time and involves extensive research and development efforts. Moreover, meeting regulatory standards and obtaining approval for new endocrine tests in clinical settings adds to the overall expenses. These various factors collectively contribute to the high cost associated with the development of endocrine testing technologies. Thus, these challenges inhibit the growth of the global endocrine testing for infertility market.
Global Endocrine Testing for Infertility Market Opportunities:
Market expansion strategies present a lucrative opportunity in the global endocrine testing for infertility market. Given the rising demand for endocrine testing for infertility owing to the rising infertility rates, a higher prevalence of conditions like PCOS and obesity, and increased awareness about fertility, businesses specializing in endocrine testing services for infertility can stand to gain significantly from this opportunity by expanding their services to emerging markets, including China, India, and Brazil. This development will help companies to increase their customer base and boost their overall revenue.
COVID-19 Impact on the Global Endocrine Testing for Infertility Market:
The outbreak of the COVID-19 pandemic substantially impacted the global endocrine testing for infertility market. The pandemic caused disruptions in supply chains and distribution of goods and services, which highly affected the provision of endocrine testing services. Moreover, the shifted focus of healthcare infrastructure resources and personnel to COVID-19 testing and treatment further declined the demand for endocrine testing services. These factors negatively impacted the growth of the global endocrine testing for infertility market. Despite these challenges, the global endocrine testing for infertility market is projected to recover and grow in the coming years.
Global Endocrine Testing for Infertility Market Recent Developments:
In February 2023, Reproductive Medicine Associates (RMA) expanded its presence by opening a fertility center in Houston, Texas. Located at 888 Westheimer Road, Suite 200 in the Montrose area, the new clinic offers comprehensive and patient-centered fertility assessment and treatment services. With a focus on convenience, RMA aims to help individuals and couples achieve their family-building goals in one accessible location. Intrauterine insemination (IUI), in vitro fertilization (IVF), preimplantation genetic testing (PGT), and egg freezing are among the treatments available at the center. RMA is committed to supporting diverse family types, offering resources and options for LGBTQ+ individuals and single individuals to start their family-building journeys.
In August 2022, Mira Fertility unveiled the Ovum Wand, a novel product catering to women aged 35 and above, to predict menopause and monitor fertility status. This innovative offering by Mira Fertility measures the levels of follicle-stimulating hormone (FSH) in urine. FSH is responsible for stimulating follicle growth and triggering ovulation.
In August 2020, DiaSorin received CE marking for its Liaison Testosterone xt test, allowing it to be launched in European countries and other regions that accept the CE designation. The test precisely identifies reproductive abnormalities including hypogonadism in males and hyperandrogenism in females by measuring testosterone levels in both genders. This approval expands DiaSorin's existing portfolio of fertility and endocrinology tests available on the Liaison XL instrument. The Liaison Testosterone xt test provides valuable diagnostic information and assists healthcare professionals in diagnosing and monitoring reproductive system-related disorders.
ENDOCRINE TESTING FOR INFERTILITY MARKET REPORT COVERAGE:
REPORT METRIC
DETAILS
Market Size Available
2022 - 2030
Base Year
2022
Forecast Period
2023 - 2030
CAGR
8.31%
Segments Covered
By Test Type, Technology, End User, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
Regional Scope
North America, Europe, APAC, Latin America, Middle East & Africa
Key Companies Profiled
Agilent Technologies (United States), Abbott Laboratories (United States), LabCorp (United States), Roche Holding AG (Switzerland), AB Sciex LLC (United States), Tosoh Bioscience, Inc. (United States)), Diazyme Laboratories, Inc. (United States), MilliporeSigma (United States), Endogenetic Life Sciences Private Limited (India), Quest Diagnostics Incorporated (United States)
Global Endocrine Testing for Infertility Market Segmentation:
Global Endocrine Testing for Infertility Market Segmentation: By Test Type
Estradiol Test
Human Chorionic Gonadotropin (hCG) Hormone Test
Luteinizing Hormone (LH) Test
Progesterone Test
Prolactin Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Others
In 2022, the human chorionic gonadotropin (hCG) test segment held the highest market share. The growth can be attributed to the widespread availability of user-friendly self-test pregnancy kits and the need for quantitative measurement of hCG in hospitals and laboratories. Additionally, the use of hCG level determination for detecting abnormalities during different stages of pregnancy, coupled with the increasing number of women of reproductive age, has further fueled the revenue generation in this segment. The utilization of hCG in infertility therapy for both men and women is also projected to propel the growth of the infertility endocrine testing market.
Global Endocrine Testing for Infertility Market Segmentation: By Technology
Chromatography
Immunoassay
Mass Spectroscopy
Others
In 2022, the immunoassay segment held the highest market share. The growth can be attributed to the availability of a variety of instruments and analyzers that utilize different immunoassay technologies for detection purposes. Additionally, many key players in the market offer a panel of immunoassay-based tests for assessing endocrine and reproductive function, which further contributes to the segment's high revenue generation.
Global Endocrine Testing for Infertility Market Segmentation: By End User
Clinical Laboratories
Diagnostic Centers
Hospitals
Others
In 2022, the clinical laboratories segment held the highest market share. The growth can be attributed to the availability of specialized and effective diagnostic procedures, as well as growing awareness of endocrine disorders. The expansion of clinical laboratory chains with advanced infrastructure and a diverse range of testing services for various diseases is anticipated to fuel further revenue growth in this segment. Moreover, the use of advanced screening methods in clinical laboratories enhances patient preference for these services.
Global Endocrine Testing for Infertility Market Segmentation: By Region
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The region of North America held the largest share of the global endocrine testing for infertility market in the year 2022. The rising incidence of infertility cases, the presence of well-established healthcare infrastructure in nations, such as the United States and Canada, and the increasing government funding initiatives aimed at improving healthcare settings are some of the factors propelling the region's growth. Additionally, North America is home to several significant market players, including Agilent Technologies, Abbott Laboratories, LabCorp, AB Sciex LLC, Tosoh Bioscience, Inc., and Diazyme Laboratories, Inc.
Due to the rising development of the medical and diagnostics industry in nations, such as China and India, improvements in healthcare systems, and an increase in personal healthcare expenditure, the region of Asia-Pacific is anticipated to expand at the fastest rate over the forecast period.
Global Endocrine Testing for Infertility Market Key Players:
Agilent Technologies (United States)
Abbott Laboratories (United States)
LabCorp (United States)
Roche Holding AG (Switzerland)
AB Sciex LLC (United States)
Tosoh Bioscience, Inc. (United States))
Diazyme Laboratories, Inc. (United States)
MilliporeSigma (United States)
Endogenetic Life Sciences Private Limited (India)
Quest Diagnostics Incorporated (United States)
To Learn more about this report,
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Key Market Insights:
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
Global Automotive Lighting Market Drivers:
Using cutting-edge technology to illuminate the road, safety serves as a guiding light.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Beyond Performance-Based Luxuries Redefined by Light.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
Fuel Efficiency Takes the Lead: Illuminating Sustainability
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
To Learn more about this report,
Global Automotive Lighting Market Restraints and Challenges:
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
Global Automotive Lighting Market Opportunities:
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
AUTOMOTIVE LIGHTING MARKET REPORT COVERAGE:
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Application
Exterior Lighting
Interior Lighting
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
Global Automotive Lighting Market Segmentation: By Technology
Halogen
LED (Light-Emitting Diode)
Xenon
Emerging Technologies
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Global Automotive Lighting Market Segmentation: By Vehicle Type
Passenger Cars
Commercial Vehicles
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Global Automotive Lighting Market Segmentation: By Sales Channel
OEM (Original Equipment Manufacturers)
Aftermarket
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Region
North America
Asia-Pacific
Europe
South America
Middle East and Africa
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
COVID-19 Impact Analysis on the Global Automotive Lighting Market:
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
Recent Trends and Developments in the Global Automotive Lighting Market:
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Fill out the form below and our team will get back to you shortly
FAQ's
Global Endocrine Testing for Infertility Market is estimated to be worth USD 294.43 Million in 2022 and is projected to reach a value of USD 557.61 Billion by 2030, growing at a CAGR of 8.31% during the forecast period 2023-2030.
The Global Endocrine Testing for Infertility Market Drivers is the declining fertility rate and the increasing WHO initiative towards fertility care.
Based on the Test Type, the Global Endocrine Testing for Infertility Market is segmented into Estradiol Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Progesterone Test, Prolactin Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, and Others.
The United States is the most dominating country in the region of North America for the Global Endocrine Testing for Infertility Market.
Agilent Technologies, Abbott Laboratories, and LabCorp are the leading players in the Global Endocrine Testing for Infertility Market.
More related reports
Get expert-driven market research reports from a leading research partner to help you navigate the future of the global industry.
Report Code: VMR-19361 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Newborn Screening Market was valued at approximately USD 6.14 Billion. It is projected to grow at a CAGR of around 7.6% during the forecast period of 2026–2030, reaching an estimated USD 8.86 Billion by 2030...
Report Code: VMR-19360 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19359 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19358 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Clinical Microbiology Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41 Bi...
Report Code: VMR-19356 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Global Fertility Services & IVF Technology Market was valued at approximately USD 53 Billion and is projected to reach around USD 82.30 Billion by 2030, expanding at a CAGR of about 9.2% during 2026–2030.
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”